A Efficacy and Safety Study of Fostamatinib in the Treatment of Persistent/Chronic Immune Thrombocytopenic Purpura (ITP)

PHASE3CompletedINTERVENTIONAL
Enrollment

74

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

August 31, 2016

Study Completion Date

August 31, 2016

Conditions
Immune Thrombocytopenic Purpura
Interventions
DRUG

Fostamatinib Disodium

Fostamatinib Disodium tablet 100 mg or 150 mg PO bid (morning and evening) over the course of 24 weeks.

DRUG

Placebo

Placebo tablet PO bid (morning and evening)

Trial Locations (35)

1090

Medizinische Universitaet Wien / AKH Wien, Vienna

1140

Hanusch-Krankenhaus Wiener Gebietskrankenkasse, Vienna

1431

UMHAT Aleksandrovska, EAD, Clinic of Clinical Hematology, Sofia

1606

Sykehuset Østfold Fredrikstad, Fredrikstad

1756

Specialized Hospital for Active Treatment of Hematology Diseases, EAD, Sofia, Department of Chemotherapy, Hemotherapy and Blood Inherited Diseases to Clinic of Clinical Hematology;, Sofia

3000

MHAT Hristo Botev, AD, Vratsa, First Internal Department, Vratsa

5021

Haukeland University Hospital, Bergen

5800

UMHAT Dr. Georgi Stranski, EAD, Pleven, Clinic of Hematology, Pleven

6830

LKH Feldkirch at LKH Rankweil, Rankweil

10960

Hematology Oncology Associates of Rockland Division of Highland Medical PC, Nyack

12203

Charit Berlin - Campus Benjamin Franklin, Berlin

28046

Hospital Universitariola Paz, Madrid

30159

Werlhof Institut GmbH, Hanover

35392

Universitaetsklinikum Giessen und Marburg (UKGM), Giessen

40479

Marien Hospital Duesseldorf, Düsseldorf

45147

Universittsklinikum Essen, Essen

46026

Hospital Universitari i Politécnic La Fe de Valencia, Valencia

69733

Hospital Kyjov, Kyjov

540136

Spitalul Clinic Judetean de Urgenta Tirgu-Mures, Sectia Medicina Interna 1, Compartiment Hematologie, Târgu Mureş

625 00

Fakultni nemocnice Brno, Brno

708 52

Fakultni nemocnice Ostrava, Ostrava-Poruba

100 34

Fakultni nemocnice Kralovske Vinohrady, Prague

128 08

Vseobecna fakultni nemocnice, Linterní Klinika, Klinika hematologie, Prague

80-952

Uniwersyteckie Centrum Kliniczne, Gdansk

31-501

Szpital Uniwersytecki, Krakow

93-510

Wojewódzki Szpital Specjalistyczny im. M. Kopernika w Łodzi, Lodz

20-081

Specjalistyczny Gabinet Lekarski, Lublin

45-064

Szpital Wojewodzki w Opolu, Opole

76-200

Wojewodzki Szpital Specjalistyczny im. J. Korczaka, Słupsk

02-776

Instytut Hematologii I Transfuzjologii, Warsaw

50-367

Samodzielny Publiczny Szpital Kliniczny Nr 1 we Wrocrlaw, Wroclaw

020125

Spitalul Clinic Colentina, Hematologie, Bucharest

030171

Spitalul Clinic Coltea, Hematologie, Bucharest

08035

Hospital Universitari Vall D'Hebron, Barcelona

08916

Hospital Universitari Germans Trias i Pujol, Barcelona

Sponsors
All Listed Sponsors
lead

Rigel Pharmaceuticals

INDUSTRY

NCT02076412 - A Efficacy and Safety Study of Fostamatinib in the Treatment of Persistent/Chronic Immune Thrombocytopenic Purpura (ITP) | Biotech Hunter | Biotech Hunter